WY vs ZVRA · P/E 43, rev $3.59B vs P/E 6.3, rev $75.9M
Weyerhaeuser Company (WY) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
WY currently screens at market cap $17.54B and trailing P/E 43.4. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the WY and ZVRA stock pages for the full models.
Not investment advice.